Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management under the brand name Mounjaro and for chronic weight management as Zepbound
Drugs such as methotrexate, levodopa, diuretics, and sulfa drugs can also have altered effectiveness or metabolism when used in conjunction with this product
If using in the morning, follow with SPF for added skin protection
Hum Mol Genet 28(19):31993210
Patel, P., Antoniou, G., Clark, D., Ketteridge, D
Its expected that 4 mg, 8 mg, and 12 mg once weekly will be the maintenance doses for retatrutide